Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (29086)	7/21/1999 5:00:00 PM
From: Arthur Radley	Respond to of 32384

OT: I need help in identifying a company name. The company is in final stages of getting FDA approval for a blood test product to detect ovarian cancer. Any help from you "biotechies" will be appreciated.

To: Henry Niman who wrote (29086)	7/21/1999 5:11:00 PM
From: Dan Breslau	Read Replies (1) \| Respond to of 32384

That's pretty easy to check out... From options.nasdaq-amex.com : Description of Index The Biotechnology Index is designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Equal-Dollar Weighting The Index is equal-dollar weighted, designed to ensure that each of its component securities is represented in approximate equal dollar value. Equal-dollar weighting was established by designating the number of shares of each component security that represented approximately $10,000 in market value, based on closing prices on Oct. 18, 1991 (e.g., a stock that closed at $20 per share would be represented in the Index by 500 shares for a total market value of $10,000). The aggregate value of the stocks was reduced by a divisor (initially 750.1506) to establish an Index benchmark value of 200.00. To ensure that each component stock continues to represent approximate equal market value, adjustments are made quarterly after the close of trading on the third Friday of January, April, July and October. Index Components Advanced Tissue Sciences Inc. (ATIS) Genzyme Corporation (GENZ) Amgen Inc. (AMGN) Gilead Sciences Inc. (GILD) Bio-Technology General Corp.(BTGC) Immune Response Corporation(IMNR) Biogen, Inc. (BGEN) Immunex Corporation (IMNX) Centocor Inc. (CNTO) Medimmune Inc.(MEDI) Cephalon, Inc. (CEPH) Organogenesis Inc. (ORG) Chiron Corporation (CHIR) Protein Design Labs,Inc. (PDLI) COR Therapeutics,Inc. (CORR) Note that the index is dollar weighted, so the size of the larger, profitable companies doesn't necessarily overweight them with respect to the smaller ones. (It depends entirely on share value.) BTW, I'm long lgnd...

To: Henry Niman who wrote (29086)	7/21/1999 5:18:00 PM
From: Wallace Rivers	Read Replies (1) \| Respond to of 32384

Henry, go ahead - per usual, spin anything the way you want to spin it. We're used to that. This is not "my" biotech index. This is the Biotech Index traded on the Amex. You'll never admit it, but the stock is an underperformer, and most certainly has seen no sustained "Breakout!" since thread inception. Some might even go so far as to call it a dog. And just because you "think" that this index is comprised of "a small number of large profitable biotechs" doesn't necessarily make what you "think" fact.